MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB

被引：0
|
作者：
Rice, Ceara [1 ]
Ghandi-Das, Dhivya [1 ]
Negi, Anurag [1 ]
机构：
[1] Univ Hosp Wales, Rheumatol, Cardiff, Wales
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [41] The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis
    Gamonet, Clementine
    Deschamps, Marina
    Marion, Sandrine
    Herbein, Georges
    Chiocchia, Gilles
    Auger, Isabelle
    Saas, Philippe
    Ferrand, Christophe
    Toussirot, Eric
    RHEUMATOLOGY, 2015, 54 (09) : 1744 - 1745
  • [42] Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris
    El Tal, Abdul Kader
    Posner, Marshall R.
    Spigelman, Zachary
    Ahmed, A. Razzaque
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) : 449 - 459
  • [43] Loss of CD20 expression on CLL cells following treatment with rituximab
    Poirot, Brigitte
    Chedani, Hicham
    Abbed, Karim
    Tertian, Gerard
    Raphael, Martine
    Besson, Caroline
    HEMATOLOGIE, 2010, 16 (01): : 92 - 95
  • [44] Loss of CD20 expression in relapsed lymphomas after rituximab therapy
    Haidar, JH
    Shamseddine, A
    Salem, Z
    Mrad, YA
    Nasr, MR
    Zaatari, G
    Bazarbachi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (05) : 330 - 332
  • [45] Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99
    Galadima, Makchit
    Kotova, Iuliia
    Schmidt, Ronny
    Pastor, Josep
    Schroeder, Christoph
    Enric Rodriguez-Gil, Joan
    Rivera del Alamo, Maria Montserrat
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [46] Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti- CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
    Wada, Naoki
    Kohara, Masaharu
    Ogawa, Hiroyasu
    Sugiyama, Haruo
    Fukuhara, Shirou
    Tatsumi, Yoichi
    Kanamaru, Akihisa
    Hino, Masayuki
    Kanakura, Yuzuru
    Morii, Eiichi
    Aozasa, Katsuyuki
    CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 194 - 201
  • [47] CHARACTERIZATION OF A PATIENTS' ANTIBODIES TO THE ANTI-CD20 THERAPEUTIC RITUXIMAB
    Mahadik, Younis
    Young, Stephen
    Morgan, Matthew
    Gordon, Caroline
    Harper, Lorraine
    RHEUMATOLOGY, 2012, 51 : 142 - 143
  • [48] HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies
    Bobrowicz, Malgorzata
    Dwojak, Michal
    Pyrzynska, Beata
    Stachura, Joanna
    Muchowicz, Angelika
    Berthel, Elise
    Dalla-Venezia, Nicole
    Kozikowski, Mieszko
    Siernicka, Marta
    Miazek, Nina
    Zapala, Piotr
    Domagala, Antoni
    Bojarczuk, Kamil
    Malenda, Agata
    Barankiewicz, Joanna
    Graczyk-Jarzynka, Agnieszka
    Zagozdzon, Agnieszka
    Gabrysiak, Magdalena
    Diaz, Jean-Jacques
    Karp, Marta
    Lech-Maranda, Ewa
    Firczuk, Malgorzata
    Giannopoulos, Krzysztof
    Efremov, Dimitar G.
    Laurenti, Luca
    Baatout, Dunja
    Frenzel, Lukas
    Malinowska, Agata
    Slabicki, Mikolaj
    Zenz, Thorsten
    Zerrouqi, Abdessamad
    Golab, Jakub
    Winiarska, Magdalena
    BLOOD, 2017, 130 (14) : 1628 - 1638
  • [49] Relapsed follicular lymphoma.: Response to Fludarabine-Mitoxantrone regimen and monoclonal anti CD20 (Rituximab).
    Giraldo, P
    Pelegrín, F
    Palomera, L
    Recasens, V
    Nájera, MJ
    Puente, F
    Perdiguer, L
    Rubio-Félix, D
    BLOOD, 2000, 96 (11) : 730A - 730A
  • [50] MODULATION OF CD20 EXPRESSION ON B CELLS BY ANTI-CD20 ANTIBODIES
    Bellintani, Elaine C.
    de Marco, Renato
    Fantini, Renata
    Valim, Tiago
    Macedo, Denise
    Miyamoto, Yuriko
    Temin, Julia
    Gerbase-DeLima, Maria
    HUMAN IMMUNOLOGY, 2016, 77 : 138 - 138
12345